No insider purchase over the last 90 days. The latest was filed 05 Jan 2026.
Onward Medical N.V. belongs to the Health Care sector. Filings by its managers are published through AFM. The last twelve months, up to 18 October 2026, brought 11 filings signed by 3 insiders.
On the market, 1 insider bought (1 purchase) while 2 insiders sold (9 sales totalling €755k). The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €500k, the sale published on 2 April 2026 by D.L. Marver is the largest of the period (0.31% of market cap). Among those who bought: 1 senior executive.
The most recent open-market purchase was published on 5 January 2026, 286 days ago. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Across the 126 companies tracked on its exchange, the median is 7 filings; at 11 filings, this issuer sits above that mark. Looking back to 2021, when coverage begins, insiders filed 13 purchases and 9 sales.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. These figures are compiled from regulatory filings published by AFM. They describe what insiders did and are not a recommendation.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
· cache
24 of 24 declarations
Onward Medical N.V. is a company focused on developing innovative solutions for restoring motor function in individuals with spinal cord injuries. It is listed on the Amsterdam Stock Exchange (XAMS).
Purchases our model currently ranks for the recommendations list.
All recommendations